ID

34161

Descripción

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232); ODM derived from: https://clinicaltrials.gov/show/NCT01881932

Link

https://clinicaltrials.gov/show/NCT01881932

Palabras clave

  1. 14/1/19 14/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

14 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01881932

Eligibility Breast Cancer NCT01881932

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven stage i-iii carcinoma of the breast or histologically proven stage i-iii colorectal carcinoma.
Descripción

ID.1

Tipo de datos

boolean

receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
Descripción

ID.2

Tipo de datos

boolean

while on chemotherapy, develop greater than or equal to nci-ctc grade 2 cipn.
Descripción

ID.3

Tipo de datos

boolean

eastern cooperative oncology group performance status 0-2.
Descripción

ID.4

Tipo de datos

boolean

the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior acupuncture within one year of enrollment.
Descripción

ID.6

Tipo de datos

boolean

known metastatic (stage iv) breast or colorectal cancer involvement.
Descripción

ID.7

Tipo de datos

boolean

pre-existing peripheral neuropathy before chemotherapy is initiated
Descripción

ID.8

Tipo de datos

boolean

currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Breast Cancer NCT01881932

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically proven stage i-iii carcinoma of the breast or histologically proven stage i-iii colorectal carcinoma.
boolean
ID.2
Item
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
boolean
ID.3
Item
while on chemotherapy, develop greater than or equal to nci-ctc grade 2 cipn.
boolean
ID.4
Item
eastern cooperative oncology group performance status 0-2.
boolean
ID.5
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
prior acupuncture within one year of enrollment.
boolean
ID.7
Item
known metastatic (stage iv) breast or colorectal cancer involvement.
boolean
ID.8
Item
pre-existing peripheral neuropathy before chemotherapy is initiated
boolean
ID.9
Item
currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial